02.23.2021 - By ReachMD
Host: John Buse, MD, PhD
Guest: David Wheeler, MB, CHB, MD, FRCP
Recent research has revealed that a type 2 diabetes treatment may help manage chronic kidney disease. Dr. John Buse discusses the use of dapagliflozin in patients with chronic kidney disease with Dr. David Wheeler, a professor of kidney medicine at the University College London in the United Kingdom, and an honorary consultant nephrologist at the Royal Free London NHS Foundation Trust.